Alternating pH and Mannose for Urinary Tract Infection Treatment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for urinary tract infections (UTIs), particularly those caused by antibiotic-resistant Escherichia coli, face challenges such as bacterial resistance to antibiotics and adverse effects on normal flora, necessitating an alternative and effective prevention or treatment method.

Innovation Solution

A composition comprising a pH increasing agent, a pH decreasing agent, and mannose or its analogue mannitol, administered alternately to create pH stress in the urinary tract, inhibiting bacterial growth and adhesion, thereby treating, inhibiting, or preventing UTIs without contributing to antibiotic resistance or disrupting normal flora.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If antibiotics are used to treat UTI, then bacterial infection is eliminated, but antibiotic resistance develops and normal flora is disrupted

Engineering Contradiction:
ImproveUTI treatment effectivenessVSAvoidantibiotic resistance and flora disruption
Core Design Contradiction:
ReliabilityVSObject-generated harmful factors

Solution Approach 1:

Mannose acts as an intermediary substance that binds to bacterial adhesion molecules (lectins) on E. coli, preventing the bacteria from attaching to urinary tract cells. This mediates the treatment effect without using antibiotics, thereby eliminating the harmful side effects of antibiotic resistance and flora disruption while maintaining treatment effectiveness

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent alternates between alkaline (pH 8.0) and acidic (pH 5.0) conditions in the urinary tract. This parameter change creates a stress environment that inhibits bacterial growth and adhesion, enhancing the overall treatment effect while avoiding antibiotic use

Inventive Principle:
Principle #35Parameter changes

2Object-affected harmful factors

If pH is altered to inhibit bacterial growth, then bacterial adhesion is reduced, but bacterial growth may be affected between pH changes

Engineering Contradiction:
Improvebacterial adhesionVSAvoidbacterial growth stability
Core Design Contradiction:
Object-affected harmful factorsVSStability of the object's composition

Solution Approach 1:

The patent implements periodic alternation between alkaline and acidic pH conditions in the urinary tract. This periodic action prevents bacteria from adapting to a single pH environment, continuously inhibiting bacterial growth and adhesion while maintaining treatment effectiveness over time

Inventive Principle:
Principle #19Periodic action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The alternating pH administration pattern effectively reduces bacterial growth and adhesion, potentiating the anti-adhesion effect of mannose, providing an efficient treatment for UTIs that does not lead to antibiotic resistance and minimizes side effects on the gastrointestinal microflora, as demonstrated by experimental data showing reduced bacterial levels and prevention of UTI recurrence.

Implementation Method 1

mannose seems to prevent UTI-causing bacteria from attaching and binding to the walls of the urinary tract and bladder. Mannose binds to lectin molecules on the cell walls of UTI-causing bacteria

Methodology Applied
Scientific EffectMannose binding to lectins: Absorption (physical)

Implementation Method 2

the unexpected discovery that the effect of mannose and analogues thereof with regard to UTI can be significantly improved by exposing the UTI-causing bacteria to a stress to inhibit cell growth. This inhibition of cell growth is, according to the embodiments, achieved by exposing the UTI-causing bacteria to changes in pH in the urinary tract system

Methodology Applied
Scientific EffectpH stress effect: Phase Change

Data Source

PatentEP3164138B1Treatment of urinary tract infection
Publication Date: 2021.05.05 BIOMEDICALS SWEDEN
  • EP3164138B1 patent drawing

AI summary

The embodiments relate to compositions useful in the treatment, inhibition or prevention of urinary tract infection in a subject. The compositions comprise a pH increasing agent, a pH decreasing agent and man nose or an analogue thereof. The pH increasing agent and the pH decreasing agent are provided to be alternately administered to the subject.